| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | Chief R&D Officer | Stock Option (right to buy) | 105,000 | 05 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 1 | $0 | 4 | Chief R&D Officer | 09 Feb 2026, 16:42 |
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 0 | $0 | 3 | Chief R&D Officer | 05 Feb 2026, 13:05 |